Emily’s Entourage (EE) is an innovative 501(c)3 that accelerates research for people in the final 10% of the cystic fibrosis (CF) population who do not benefit from existing CFTR modulators. Since 2011, EE has awarded millions of dollars in research grants, launched a clinical-stage CF gene therapy company, developed a global patient database and clinical trial matchmaking program to accelerate trial recruitment, and led worldwide efforts to drive high-impact research and drug development.
